Literature DB >> 19003972

EMMPRIN (basigin/CD147) expression is not correlated with MMP activity during adult mouse mammary gland development.

Malgorzata Szymanowska1, Kay A K Hendry, Claire Robinson, Andreas F Kolb.   

Abstract

Extracellular matrix metalloproteinase inducer (EMMPRIN/basigin/CD147) is a cell surface protein, which has been associated with the induction of matrix metalloproteinase (MMP) genes during cancer metastasis. EMMPRIN plays a role in a variety of physiological processes as is evident by the diverse deficiencies detectable in EMMPRIN knockout mice. We have analysed the role of EMMPRIN in the induction of MMP genes during mammary gland differentiation and involution. Co-transfection studies showed that EMMPRIN has diverse effects on MMP promoter activity in different mammary and non-mammary cell lines. Expression of EMMPRIN mRNA is enhanced markedly by insulin in a mammary gland cell line but appears to have no direct effect on MMP gene expression in these cells. Microarray analysis and quantitative PCR show that EMMPRIN is expressed throughout mammary gland differentiation in the mouse. Its expression decreases during early pregnancy and briefly after induction of mammary gland involution by litter removal. Immunohistochemical analysis shows that EMMPRIN expression is limited to the stromal compartment during pregnancy, whereas it is strongly expressed in the epithelium during lactation. In summary the data argue against a causal role for EMMPRIN for the induction of MMP gene expression during adult mammary gland development. These data therefore support a physiological role for EMMPRIN other than MMP induction in mammary gland biology. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19003972     DOI: 10.1002/jcb.21975

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  EMMPRIN regulates cytoskeleton reorganization and cell adhesion in prostate cancer.

Authors:  Haining Zhu; Jun Zhao; Beibei Zhu; Joanne Collazo; Jozsef Gal; Ping Shi; Li Liu; Anna-Lena Ström; Xiaoning Lu; Richard O McCann; Michal Toborek; Natasha Kyprianou
Journal:  Prostate       Date:  2011-05-11       Impact factor: 4.104

2.  Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its related extracellular matrix degrading enzymes in the endometrium during estrous cycle and early gestation in cattle.

Authors:  Birendra Mishra; Keiichiro Kizaki; Katsuo Koshi; Koichi Ushizawa; Toru Takahashi; Misa Hosoe; Takashi Sato; Akira Ito; Kazuyoshi Hashizume
Journal:  Reprod Biol Endocrinol       Date:  2010-06-11       Impact factor: 5.211

3.  Milk lacking α-casein leads to permanent reduction in body size in mice.

Authors:  Andreas F Kolb; Reinhard C Huber; Simon G Lillico; Ailsa Carlisle; Claire J Robinson; Claire Neil; Linda Petrie; Dorte B Sorensen; I Anna S Olsson; C Bruce A Whitelaw
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

4.  MMP3-mediated tumor progression is controlled transcriptionally by a novel IRF8-MMP3 interaction.

Authors:  Debarati Banik; Colleen S Netherby; Paul N Bogner; Scott I Abrams
Journal:  Oncotarget       Date:  2015-06-20

5.  Knock out of the BASIGIN/CD147 chaperone of lactate/H+ symporters disproves its pro-tumour action via extracellular matrix metalloproteases (MMPs) induction.

Authors:  Ibtissam Marchiq; Jean Albrengues; Sara Granja; Cédric Gaggioli; Jacques Pouysségur; Marie-Pierre Simon
Journal:  Oncotarget       Date:  2015-09-22

Review 6.  How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity.

Authors:  G Daniel Grass; Bryan P Toole
Journal:  Biosci Rep       Date:  2015-11-24       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.